Univest
Univest
  • Markets

Gujarat Kidney And Super Speciality vs Nifty 50: Returns Compared

  • September 25, 2026
  • Posted by: Kunal Singla
  • Category: Market
No Comments
Gujarat Kidney And Super Speciality vs Nifty 50: Returns Compared

Gujarat Kidney And Super Speciality share price Rs 172.41 on NSE. Gujarat Kidney And Super Speciality vs Nifty 50 over 1M: +13.09% vs -5.22%. 52-week high Rs 186.99, low Rs 98.36.

Quick Answer

Gujarat Kidney And Super Speciality vs Nifty 50 over the last 1M shows Gujarat Kidney And Super Speciality at +13.09% against the Nifty 50’s -5.22%, with limited comparable trading history available for longer periods. With limited comparable trading history, longer-term comparisons against the Nifty 50 are not yet meaningful for this stock. Investors comparing the two should also weigh Gujarat Kidney And Super Speciality’s trading liquidity, valuation and sector context rather than relying on returns alone.

Gujarat Kidney And Super Speciality vs Nifty 50 is a comparison that looks different depending on the time frame chosen. Gujarat Kidney And Super Speciality trades on the NSE under the symbol GKSL, and its 1M return of +13.09% compares with the Nifty 50’s -5.22% over the same period.

The Gujarat Kidney And Super Speciality vs Nifty 50 comparison matters because Gujarat Kidney And Super Speciality is a single stock exposed to its own sector and company-specific developments, while the Nifty 50 spreads risk across 50 large companies. This article lines up Gujarat Kidney And Super Speciality share price performance against the Nifty 50 across 1 month, 3 months, 6 months, using NSE closing data.

Also read – Godrej Agrovet vs Nifty 50: Share Price Performance Compared

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Gujarat Kidney And Super Speciality vs Nifty 50: Performance at a Glance
  • Why the Gujarat Kidney And Super Speciality vs Nifty 50 Gap Exists
  • Gujarat Kidney And Super Speciality vs Nifty 50: Has Gujarat Kidney And Super Speciality Beaten the Benchmark?
  • Risks of the Gujarat Kidney And Super Speciality vs Nifty 50 Comparison
  • Conclusion
    • What is the Gujarat Kidney And Super Speciality share price today compared to Nifty 50?
    • What is the 52-week high and low of Gujarat Kidney And Super Speciality?
    • Why does Gujarat Kidney And Super Speciality show bigger price swings than the Nifty 50?
    • Is Gujarat Kidney And Super Speciality a good long-term investment compared to a Nifty 50 index fund?

Gujarat Kidney And Super Speciality vs Nifty 50: Performance at a Glance

The table below sets out Gujarat Kidney And Super Speciality vs Nifty 50 performance across the available time frames, measured from NSE closing prices up to 25 September 2026.

Time Frame Gujarat Kidney And Super Speciality Return Nifty 50 Return Difference
1 Month +13.09% -5.22% +18.31% pp
3 Months +33.41% -4.13% +37.54% pp
6 Months +67.31% (Gujarat Kidney And Super Speciality) -1.04% (Nifty 50) +68.35% pp

On the Gujarat Kidney And Super Speciality vs Nifty 50 scorecard, Gujarat Kidney And Super Speciality’s comparable trading history currently limits the comparison to shorter time frames.

Check the Univest Screener for live Gujarat Kidney And Super Speciality and Nifty 50 data

Why the Gujarat Kidney And Super Speciality vs Nifty 50 Gap Exists

Gujarat Kidney And Super Speciality’s stock can move quite differently from the Nifty 50 because it carries concentrated exposure to its own sector and business cycle, unlike the index which blends 50 companies across banking, IT, energy and consumer sectors. This is the main driver of the gap seen in the Gujarat Kidney And Super Speciality vs Nifty 50 return table above.

A second factor behind the Gujarat Kidney And Super Speciality vs Nifty 50 divergence is valuation and trading liquidity. Company-specific news, quarterly results and sector sentiment can move Gujarat Kidney And Super Speciality’s price sharply in either direction over short periods, while the Nifty 50’s return reflects the blended earnings trajectory of its constituents and is far less exposed to any single stock’s swings.

Download the Univest iOS App or Univest Android App to track Gujarat Kidney And Super Speciality and Nifty 50 live on the go.

Gujarat Kidney And Super Speciality vs Nifty 50: Has Gujarat Kidney And Super Speciality Beaten the Benchmark?

With Gujarat Kidney And Super Speciality’s comparable trading history currently limited, the clearest Gujarat Kidney And Super Speciality vs Nifty 50 comparison available is over 1M, where the stock returned +13.09% against the Nifty 50’s -5.22%.

Also read – Goodluck India vs Nifty 50: Share Price Performance Compared

Risks of the Gujarat Kidney And Super Speciality vs Nifty 50 Comparison

Reading too much into a Gujarat Kidney And Super Speciality vs Nifty 50 comparison has real limitations that investors should weigh before drawing conclusions. Gujarat Kidney And Super Speciality carries concentrated business and sector risk that a diversified index does not, and its trading volumes and price swings can differ meaningfully from the Nifty 50’s more liquid, blended profile. A stock’s 52-week range of Rs 98.36 to Rs 186.99 also shows the kind of volatility that a single-stock investment carries relative to a broad index.

Conclusion

Gujarat Kidney And Super Speciality vs Nifty 50 highlights how a single stock’s return path can differ from a diversified benchmark over different time horizons. Investors weighing the Gujarat Kidney And Super Speciality vs Nifty 50 record should factor in Gujarat Kidney And Super Speciality’s volatility, liquidity and sector concentration alongside its return history, and consult a SEBI-registered advisor before making an allocation decision.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

What is the Gujarat Kidney And Super Speciality share price today compared to Nifty 50?

Ans. Gujarat Kidney And Super Speciality share price stood at Rs 172.41 on NSE, while the Nifty 50 traded at 23,063.10 based on the same closing data window.

What is the 52-week high and low of Gujarat Kidney And Super Speciality?

Ans. Gujarat Kidney And Super Speciality’s 52-week high is Rs 186.99 and its 52-week low is Rs 98.36, based on NSE data.

Why does Gujarat Kidney And Super Speciality show bigger price swings than the Nifty 50?

Ans. Gujarat Kidney And Super Speciality carries concentrated exposure to its own sector and business cycle, while the Nifty 50 spreads risk across 50 large companies, so company-specific news moves Gujarat Kidney And Super Speciality’s price more sharply than the diversified index, a key reason the Gujarat Kidney And Super Speciality vs Nifty 50 return gap varies across time frames.

Is Gujarat Kidney And Super Speciality a good long-term investment compared to a Nifty 50 index fund?

Ans. Gujarat Kidney And Super Speciality’s suitability depends on an investor’s risk appetite, since single-stock exposure carries higher concentration risk than a diversified Nifty 50 index fund; long-term investors should weigh the Gujarat Kidney And Super Speciality vs Nifty 50 return history alongside the company’s fundamentals and consult a SEBI-registered advisor.



Nifty 50 Stock Market
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply